このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Magle Chemoswed Holding マネジメント

マネジメント基準チェック /24

Magle Chemoswed Holding'sの CEO はJustin Pierceで、 Jan2015年に任命され、の在任期間は 9.42年です。は、会社の株式の1.6%を直接所有しており、その価値はSEK 6.84M 。経営陣と取締役会の平均在任期間はそれぞれ4.9年と8.4年です。

主要情報

Justin Pierce

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	9.5yrs
CEOの所有権	1.6%
経営陣の平均在職期間	5yrs
取締役会の平均在任期間	8.5yrs

経営陣の近況

Recent updates

Market Participants Recognise Magle Chemoswed Holding AB (publ)'s (STO:MAGLE) Earnings Pushing Shares 37% Higher

Jun 26

Magle Chemoswed Holding (STO:MAGLE) Has A Pretty Healthy Balance Sheet

Jun 19

Magle Chemoswed Holding's (STO:MAGLE) Earnings Are Of Questionable Quality

Apr 26

Earnings Tell The Story For Magle Chemoswed Holding AB (publ) (STO:MAGLE) As Its Stock Soars 28%

Mar 29

Magle Chemoswed Holding AB (publ)'s (STO:MAGLE) Price In Tune With Earnings

Oct 05

Should You Be Impressed By Magle Chemoswed Holding AB (publ)'s (STO:MAGLE) ROE?

Jan 22

CEO（最高経営責任者

Justin Pierce (51 yo)

9.5yrs

在職期間

Mr. Justin Pierce serves as Chief Executive Officer at Magle Chemoswed Holding AB (publ) since 2015.

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Hans Lidgard	Founder & Chairman	11.5yrs	SEK 248.00k	データなし
Justin Pierce	Chief Executive Officer	9.5yrs	データなし	1.6% SEK 7.5m
Petra Sjolin	Chief Financial Officer	4.5yrs	データなし	データなし
Fredrik Andersson	Chief Operations Officer	5.5yrs	データなし	データなし
Megi Medzmariashvili	Legal Counsel	5.5yrs	データなし	データなし
Helena Thedius	Chief Marketing & Innovation Officer	1.8yrs	データなし	データなし
Simon Jegou	Chief Strategy Officer	2.5yrs	データなし	データなし

5.0yrs

平均在職期間

48yo

平均年齢

経験豊富な経営陣: MAGLEの経営陣は経験豊富で経験豊富です（平均在職期間は5年）。

取締役

名称	ポジション	在職期間	報酬	所有権
Hans Lidgard	Founder & Chairman	11.5yrs	SEK 248.00k	データなし
Sven-Christer Nilsson	Director	8.5yrs	SEK 138.00k	0.50% SEK 2.4m
Mats Pettersson	Director	8.5yrs	SEK 138.00k	2% SEK 9.4m
Claudia Lindwall	Staff Representative Director	3.5yrs	データなし	データなし
Malin Malmsjö	Director	8.5yrs	SEK 131.00k	データなし
Ingela Fritzon	Staff Representative Director	5.5yrs	データなし	データなし
Martin Lidgard	Director	2.6yrs	SEK 131.00k	0.26% SEK 1.2m

8.5yrs

平均在職期間

61yo

平均年齢

経験豊富なボード: MAGLEの取締役会は経験豊富であると考えられます ( 8.4年の平均在任期間)。

Magle Chemoswed Holding マネジメント

マネジメント 基準チェック /24

主要情報

経営陣の近況

No independent directors

No independent directors

Magle Group Appoints New Chief Marketing and Innovation Officer

Magle Chemoswed Holding AB Announces the Resignation of Julia Kamber Rouhi from the Board of Directors of Magle Chemoswed Holding

No independent directors

Magle Chemoswed Holding AB (publ), Annual General Meeting, May 17, 2022

Recent updates

Investor sentiment improves as stock rises 16%

Market Participants Recognise Magle Chemoswed Holding AB (publ)'s (STO:MAGLE) Earnings Pushing Shares 37% Higher

Magle Chemoswed Holding (STO:MAGLE) Has A Pretty Healthy Balance Sheet

Magle Chemoswed Holding's (STO:MAGLE) Earnings Are Of Questionable Quality

First quarter 2024 earnings released: EPS: kr0.27 (vs kr0.27 in 1Q 2023)

Earnings Tell The Story For Magle Chemoswed Holding AB (publ) (STO:MAGLE) As Its Stock Soars 28%

Magle Chemoswed Holding AB (publ) (OM:MAGLE) made a tender to acquire 99.96% stake in Amniotics AB (publ) (OM:AMNI) from LSCS Invest AB, Deflexum AB, Marcus Larsson and other for SEK 10.9 million.

Full year 2023 earnings: EPS and revenues exceed analyst expectations

New minor risk - Financial data availability

Magle Chemoswed Holding AB (publ) to Report Q4, 2024 Results on Feb 26, 2025

No independent directors

New minor risk - Share price stability

Magle Chemoswed Holding AB (publ)'s (STO:MAGLE) Price In Tune With Earnings

Investor sentiment improves as stock rises 16%

Full year 2022 earnings released: EPS: kr0.87 (vs kr0.39 in FY 2021)

Magle Chemoswed Holding AB 's Proprietary Product Axxo® Woundgel Receives Regulatory Approval in Kuwait

Magle Group's Vascular Embolic Product Embocept® S Receives Regulatory Approval in Argentina

No independent directors

Magle Group Appoints New Chief Marketing and Innovation Officer

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Magle Chemoswed Holding AB Announces the Resignation of Julia Kamber Rouhi from the Board of Directors of Magle Chemoswed Holding

Magle Group Announces First Patients Enrolled in a Post-Market Study of Medical Device SmartPAN®

Magle Chemoswed Holding AB (publ) Announces Post Market Clinical Study for SmartPAN®

Magle Chemoswed Holding AB (publ) to Report Q4, 2022 Results on Feb 16, 2023

Investor sentiment deteriorated over the past week

No independent directors

Full year 2021 earnings released: EPS: kr0.39 (vs kr0.24 in FY 2020)

Magle Chemoswed Holding AB (publ), Annual General Meeting, May 17, 2022

Investor sentiment improved over the past week

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Magle Chemoswed Holding AB (publ) to Report Fiscal Year 2021 Results on Feb 25, 2022

Full year 2020 earnings released: EPS kr0.24

Should You Be Impressed By Magle Chemoswed Holding AB (publ)'s (STO:MAGLE) ROE?

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

New 90-day high: kr44.60

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Magle Chemoswed Holding AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 20 million.

New 90-day high: kr35.00

New 90-day high: kr34.60

Magle Chemoswed Holding AB (publ) to Report Fiscal Year 2020 Results on Apr 14, 2021

New 90-day high: kr33.50

New 90-day high: kr30.90

Magle Chemoswed Holding AB (Publ) Announces the Appointment of Joel Eklund as New Member of the Board

Magle Chemoswed Holding AB (publ) has completed an IPO in the amount of SEK 50 million.

CEO（最高経営責任者

在職期間

リーダーシップ・チーム

平均在職期間

平均年齢

取締役

平均在職期間

平均年齢

マネジメント基準チェック /24